Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Egypt.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
      • Thrombosis
      • Caprini risk assessment model
      • Padua risk assessment model
      • Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
      • Surgery for benign disease: Case presentation Prof. Juan Arcelus
      • VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
    • Hypertension
      • Hypertension
      • ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
    • Dyslipidemia
      • Dyslipidemia
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
      • Effect of Alirocumab on Mortality After Acute Coronary Syndromes
      • Polyvascular Disease Subanalysis
      • PACMAN AMI
      • PACMAN AMI: KOL Interview
    • Atherothrombosis
      • Atherothrombosis
      • Insights and impacts from the HOST-EXAM trial
      • Insights and impacts from the TALOS-AMI trial
  • Diabetes
    • Diabetes
    • Diabetes Your Type
    • Risk Stratification of Individuals with Diabetes before Ramadan
    • Management of Diabetes during Ramadan
    • Diabetes Overview, Complications and Guidelines
    • The BRIGHT Study
    • Sanofi's Insulin Legacy & Heritage
      • Sanofi's Insulin Legacy & Heritage
      • A legacy and heritage in insulin
      • Our Insulin Campus
    • Time in Range
      • Time in Range
      • Time In Range Infographics
      • Time in Range Study
      • The value of time-in-range as a glycemic biomarker
  • Rare Diseases
    • Rare Diseases
    • Management of Gaucher Disease
    • Clinically multidisceplinary management
    • An Overview over LSDs
    • Insights on Gaucher disease - Genetic prespective
    • Delayed Diagnosis of MPS1
    • Overview of MPS1
    • Diagnosing Gaucher Disease
    • Overview of Gaucher Disease & Clinical picture
    • Gaucher : Molecular Based Definitions
    • MPS1 : Pathogentics
  • Vaccines
    • Vaccines
    • Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
  • Asthma
    • Asthma
    • What’s the best way to talk about my Asthma?
    • I need a good asthma plan, but where do I start?
    • Optimal Asthma Control goes beyond Exacerbation Reduction
    • Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Cardiovascular
    • Cardiovascular
    • How to self-inject Clexane video
  • Diabetes
    • Diabetes
    • Toujeo Patient Support Program
    • Soliqua Patient Support Program
    • How to take Toujeo
  • Atopic Dermatitis
    • Atopic Dermatitis
    • Dupixent My Way Program
    • Atopic Dermatitis Patient Educational Flyer
  • Nasal Polys
    • Nasal Polys
    • Dupixent My Way Program
  • Asthma
    • Asthma
    • Dupixent My Way Program
    • Bronchial Asthma Patient Educational Flyer
    • Dupixent How to Use Patient Booklet
    • Dupixent FAQ Patient Booklet
PRODUCTS
  • PRODUCTS
  • Clexane®
    • Clexane®
    • Extended VTE prophylaxis in onco-surgical patients
    • Duration of treatment for VTE prophylaxis
    • Critical thrombotic period
    • One day surgery & fast track surgery thromboprophylaxis Guidelines
  • Soliqua®
    • Soliqua®
    • OAD Uncontrolled Patients
    • Basal Insulin Uncontrolled Patients
    • Premix Uncontrolled Patients
    • Soliqua 2 Pens Modeling and Dosing
    • Soliqua Useful Links
  • Depakine®
  • Dapaglif®
    • Dapaglif®
    • Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
    • Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Dupixent Asthma
      • Dupixent Asthma
      • Type 2 Asthma With Ocs Use
      • Type 2 Asthma With Comorbidities
      • Type 2 Asthma With Mixed Biomarkers
      • Type 2 Asthma With High Eos
      • Type 2 Asthma With High Ige
  • Menactra®
  • Hexaxim®
  • VaxigripTetra®
  • Toujeo®
    • Toujeo®
    • Time in Range Results
  • Praluent®
    • Praluent®
    • Know about praluent
  • Plavix
    • Plavix
    • The Cure Study
    • PCI Cure Study
EVENTS
Log-in
Register
Search
Home | go to homepage
Log-in
Register
Search
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
      • Thrombosis
      • Caprini risk assessment model
      • Padua risk assessment model
      • Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
      • Surgery for benign disease: Case presentation Prof. Juan Arcelus
      • VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
    • Hypertension
      • Hypertension
      • ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
    • Dyslipidemia
      • Dyslipidemia
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
      • Effect of Alirocumab on Mortality After Acute Coronary Syndromes
      • Polyvascular Disease Subanalysis
      • PACMAN AMI
      • PACMAN AMI: KOL Interview
    • Atherothrombosis
      • Atherothrombosis
      • Insights and impacts from the HOST-EXAM trial
      • Insights and impacts from the TALOS-AMI trial
  • Diabetes
    • Diabetes
    • Diabetes Your Type
    • Risk Stratification of Individuals with Diabetes before Ramadan
    • Management of Diabetes during Ramadan
    • Diabetes Overview, Complications and Guidelines
    • The BRIGHT Study
    • Sanofi's Insulin Legacy & Heritage
      • Sanofi's Insulin Legacy & Heritage
      • A legacy and heritage in insulin
      • Our Insulin Campus
    • Time in Range
      • Time in Range
      • Time In Range Infographics
      • Time in Range Study
      • The value of time-in-range as a glycemic biomarker
  • Rare Diseases
    • Rare Diseases
    • Management of Gaucher Disease
    • Clinically multidisceplinary management
    • An Overview over LSDs
    • Insights on Gaucher disease - Genetic prespective
    • Delayed Diagnosis of MPS1
    • Overview of MPS1
    • Diagnosing Gaucher Disease
    • Overview of Gaucher Disease & Clinical picture
    • Gaucher : Molecular Based Definitions
    • MPS1 : Pathogentics
  • Vaccines
    • Vaccines
    • Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
  • Asthma
    • Asthma
    • What’s the best way to talk about my Asthma?
    • I need a good asthma plan, but where do I start?
    • Optimal Asthma Control goes beyond Exacerbation Reduction
    • Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Cardiovascular
    • Cardiovascular
    • How to self-inject Clexane video
  • Diabetes
    • Diabetes
    • Toujeo Patient Support Program
    • Soliqua Patient Support Program
    • How to take Toujeo
  • Atopic Dermatitis
    • Atopic Dermatitis
    • Dupixent My Way Program
    • Atopic Dermatitis Patient Educational Flyer
  • Nasal Polys
    • Nasal Polys
    • Dupixent My Way Program
  • Asthma
    • Asthma
    • Dupixent My Way Program
    • Bronchial Asthma Patient Educational Flyer
    • Dupixent How to Use Patient Booklet
    • Dupixent FAQ Patient Booklet
PRODUCTS
  • PRODUCTS
  • Clexane®
    • Clexane®
    • Extended VTE prophylaxis in onco-surgical patients
    • Duration of treatment for VTE prophylaxis
    • Critical thrombotic period
    • One day surgery & fast track surgery thromboprophylaxis Guidelines
  • Soliqua®
    • Soliqua®
    • OAD Uncontrolled Patients
    • Basal Insulin Uncontrolled Patients
    • Premix Uncontrolled Patients
    • Soliqua 2 Pens Modeling and Dosing
    • Soliqua Useful Links
  • Depakine®
  • Dapaglif®
    • Dapaglif®
    • Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
    • Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Dupixent Asthma
      • Dupixent Asthma
      • Type 2 Asthma With Ocs Use
      • Type 2 Asthma With Comorbidities
      • Type 2 Asthma With Mixed Biomarkers
      • Type 2 Asthma With High Eos
      • Type 2 Asthma With High Ige
  • Menactra®
  • Hexaxim®
  • VaxigripTetra®
  • Toujeo®
    • Toujeo®
    • Time in Range Results
  • Praluent®
    • Praluent®
    • Know about praluent
  • Plavix
    • Plavix
    • The Cure Study
    • PCI Cure Study
EVENTS
  • Log-in
  • Register
  • Search
    • Home
    • Science
    • Cardiovascular
    • Thrombosis

    Thrombosis

    Science in Thrombosis

    Surgery for benign disease: Case presentation Prof. Juan Arcelus

    Caprini risk assessment model

    Padua risk assessment model

    Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella

    VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini

    SEE EVERYTHING
    Home | go to homepage
    • Privacy Policy
    • Terms & Conditions of Use
    • Cookie Policy
    • Sitemap